Delisting riskPopularity #4,747
SNTI · NASDAQ · Biotechnology

Senti Biosciences (SNTI)

Gene-circuit developer for programmable cell and gene therapies.

$0.3299
After hours+0.01 (+1.95%)
At close$0.3236(+4.39%)

Something off on this page? Send us feedback.

Next report
Nov 12, 26
estimated · in 51 days
EPS estimate
−$0.21
Revenue estimate
$15.9K
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.67−$1.41−$0.56−$0.69−$0.38−$0.14−$0.41Pending
Estimate−$3.13−$0.58−$0.90−$0.59−$0.43−$0.27−$0.27−$0.21
Surprise+78.6%−143.1%+37.8%−16.9%+11.6%+48.1%−54.7%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$5.9M$22.0K$8.0K$17.0KPending
Estimate$2.8M$1.3M$500.0K$250.0K$1.0M$16.0K$17.0K$15.9K
Surprise+109.1%−97.8%−50.0%0.0%

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2026−$0.21
Nov 2026−$0.21
Aug 2026−$0.27−$0.41−54.7%
May 2026−$0.27−$0.14+48.1%
Mar 2026−$0.43−$0.38+11.6%
Nov 2025−$0.59−$0.69−16.9%
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
Aug 2022
Mar 2022
Nov 2021
Aug 2021
Jul 2021
Dec 2020

The latest year is open to everyone — the 19 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2026−$0.21$14.8K
Nov 12, 2026−$0.21$15.9K
Aug 14, 2026−$0.27−$0.41−54.7%$17.0K$17.0K0.0%+16.9%
May 14, 2026−$0.27−$0.14+48.1%$16.0K$8.0K−50.0%+8.0%
Mar 27, 2026−$0.43−$0.38+11.6%$1.0M$22.0K−97.8%−10.4%
Nov 13, 2025−$0.59−$0.69−16.9%$250.0K−5.3%
Aug 7, 2025
May 6, 2025
Mar 20, 2025
Nov 14, 2024
Aug 13, 2024
May 9, 2024
Mar 21, 2024
Nov 13, 2023
Aug 11, 2023
May 9, 2023
Mar 22, 2023
Nov 10, 2022
Aug 15, 2022
Aug 9, 2022
Mar 7, 2022
Nov 10, 2021
Aug 6, 2021
Jul 2, 2021
Dec 31, 2020

The latest year is open to everyone — the 19 quarters behind it read with an account.